Exon-level microarray analyses identify alternative splicing programs in breast cancer.
about
Genome-wide analysis of microRNA and mRNA expression signatures in cancerConnecting the speckles: Splicing kinases and their role in tumorigenesis and treatment responseAn EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotypePersonal omics profiling reveals dynamic molecular and medical phenotypesIncreased macroH2A1.1 expression correlates with poor survival of triple-negative breast cancer patients3'UTR shortening identifies high-risk cancers with targeted dysregulation of the ceRNA network.Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal CarcinomaThe role of mRNA splicing in prostate cancer.Cyclin D1, Id1 and EMT in breast cancer.Detection and correction of probe-level artefacts on microarrays.Network enrichment analysis: extension of gene-set enrichment analysis to gene networks.WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.Efficient in vivo manipulation of alternative pre-mRNA splicing events using antisense morpholinos in mice.Interplay between estrogen receptor and AKT in estradiol-induced alternative splicingNetworking in a global world: establishing functional connections between neural splicing regulators and their target transcriptsAn integrated model of the transcriptome of HER2-positive breast cancer.Tumor microenvironment-associated modifications of alternative splicing.TIPMaP: a web server to establish transcript isoform profiles from reliable microarray probes.TBX3 regulates splicing in vivo: a novel molecular mechanism for Ulnar-mammary syndrome.Splicing programs and cancerMiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families.Leveraging transcript quantification for fast computation of alternative splicing profiles.Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteinsIdentification of mRNA isoform switching in breast cancer.EventPointer: an effective identification of alternative splicing events using junction arrays.Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapyA summary of relationships between alternative splicing and breast cancer.Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors.Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levelsRBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues.Transcriptomic analysis of PNN- and ESRP1-regulated alternative pre-mRNA splicing in human corneal epithelial cellsRNA sequencing of cancer reveals novel splicing alterations.Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes.Determination of a Comprehensive Alternative Splicing Regulatory Network and Combinatorial Regulation by Key Factors during the Epithelial-to-Mesenchymal TransitionGenome-wide analysis of alternative transcripts in human breast cancer.Exo70 isoform switching upon epithelial-mesenchymal transition mediates cancer cell invasion.Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients' survivalRbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridges.Modeling precision treatment of breast cancer
P2860
Q26795603-39D40FB2-EEF5-4456-A0F5-4B40BF5062F7Q26824298-9C9197FF-7010-480D-A891-734D5F7353FDQ27339197-CB537CF0-40E4-4658-BBAB-D0521F2EEC3EQ29614800-96FED971-398E-4F6B-8BF8-EB9791597395Q33727273-B258BFF3-5F27-44BE-9773-8AC5E2EEBB51Q33788981-1C689A83-0795-4F28-AEAC-7BF3A912AE81Q33911898-612FA72B-CD62-4FEF-96E5-8D9894559E91Q33922376-5A07E554-C600-4C5E-8776-90686E8EAA85Q34034112-C9CCE702-81BF-4175-8134-A8493E32D4EEQ34286500-57AC0918-6E8F-4D6D-85D5-45EDA8527866Q34411128-221DC70F-93CB-43DC-A4BB-9FAF069A308DQ34618790-56F7CEAB-14C2-469D-8D20-FADECB923F61Q34675818-B851DC20-3EA3-4A3E-825E-430B44766C4BQ34768156-36206ADE-C672-4C3A-8BBA-8206669E00C6Q34807839-CDECF1CB-5399-4349-AD28-3C441CC4055FQ35041257-EFC01430-A782-4E9E-BEDB-0CA72801874EQ35066327-0243DD9D-1901-47A4-9856-E25E34052611Q35076912-2169DF71-538B-45B3-A89B-2CE48A1A939DQ35133477-FD7D4C09-6D64-45A4-8E4D-6BCE930AA095Q35450183-A5A29D45-A698-4046-BF54-636FB7DD9DCEQ35644614-B93EFBE6-069E-46E3-A112-EDCB8FCCF604Q35693081-2B97E76B-5F63-430B-80C8-A6AC461DC343Q35937670-A63776E6-F6BD-4FD5-B295-8FF0DB22E84DQ35945158-3FE8831D-A94B-4A03-987B-9829F6E443CEQ36055662-EE57BF4C-DA48-436B-B1D0-DAA94567BA27Q36058024-D59034EE-FBD9-4F67-B6E4-196FD6165877Q36315850-A3F3B22B-D997-4AF6-AEFB-8301D2E07A74Q36378283-48D32086-5C60-409A-BDA0-837CA6438B2CQ36436933-7525E875-EF0B-4A69-BCB3-6CB9376B3EB2Q36557126-FB40816D-4498-4051-AADF-D17D621B0802Q36559726-85F3FDCF-8E39-4EA3-85C7-BF8686064C04Q36574065-C160F8B9-FAAE-40FA-8ABB-71D2D09EACF8Q36782437-8A0CF5CC-F111-45C2-B6EB-BFAC1F8BC303Q36838683-03EDB8E7-A0FE-4794-A7F3-66BEDE8671C6Q37122584-CCADE76E-51B5-47A4-95F2-320BFFFA7CA7Q37351529-BAAE784C-1313-4044-BCE4-DAB74897AA51Q37537855-395C5631-0B4B-4A8B-B8AD-1D40C1BCF865Q37563571-DC3A7E4C-5285-4EF0-A01A-05F7992B6873Q37570298-40EABE73-873E-46D6-A60E-C6C6519FA2B6Q37608340-6A7894C9-3844-4538-B14C-242BCAB60027
P2860
Exon-level microarray analyses identify alternative splicing programs in breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Exon-level microarray analyses identify alternative splicing programs in breast cancer.
@ast
Exon-level microarray analyses identify alternative splicing programs in breast cancer.
@en
Exon-level microarray analyses identify alternative splicing programs in breast cancer.
@nl
type
label
Exon-level microarray analyses identify alternative splicing programs in breast cancer.
@ast
Exon-level microarray analyses identify alternative splicing programs in breast cancer.
@en
Exon-level microarray analyses identify alternative splicing programs in breast cancer.
@nl
prefLabel
Exon-level microarray analyses identify alternative splicing programs in breast cancer.
@ast
Exon-level microarray analyses identify alternative splicing programs in breast cancer.
@en
Exon-level microarray analyses identify alternative splicing programs in breast cancer.
@nl
P2093
P2860
P50
P1476
Exon-level microarray analyses identify alternative splicing programs in breast cancer.
@en
P2093
Andrew Wyrobek
Anna Lapuk
Anthony Schweitzer
Elizabeth Purdom
Gerald Fontenay
Heidi Feiler
Helder Pedro
Henry Marr
Hovig Bayandorian
James Garbe
P2860
P304
P356
10.1158/1541-7786.MCR-09-0528
P577
2010-07-06T00:00:00Z